Company Filing History:
Years Active: 2022-2023
Title: Guochun Li: Innovator in FGF21-Associated Disorders
Introduction
Guochun Li is a prominent inventor based in San Diego, CA. He has made significant contributions to the field of biotechnology, particularly in the treatment of FGF21-associated disorders. With a total of 2 patents, his work has the potential to impact many lives.
Latest Patents
Li's latest patents focus on monoclonal antibodies and antigen-binding fragments that bind to human β-klotho. These inventions are crucial for developing pharmaceutical compositions and methods of treatment for FGF21-associated disorders. His innovative approach aims to provide new therapeutic options for patients suffering from these conditions.
Career Highlights
Guochun Li is currently associated with Novartis AG, a leading global healthcare company. His role at Novartis allows him to collaborate with other experts in the field and contribute to groundbreaking research and development.
Collaborations
Some of his notable coworkers include Brian R. Boettcher and Shari Lynn Caplan. Their combined expertise enhances the research efforts at Novartis and fosters an environment of innovation.
Conclusion
Guochun Li's work in the field of biotechnology, particularly regarding FGF21-associated disorders, showcases his dedication to advancing medical science. His patents and collaborations reflect a commitment to improving patient outcomes through innovative treatments.